DailyIQ
|
Sector:Financial ServicesAll sectors
Last updated 3 minutes ago

KKR·KKR & Co. Inc.

$.
+. (+.%)
After Hours
High
$99.22
Open
$98.00
Market Cap
87.04B
52W High
$153.87
Low
$95.25
P. Close
$96.94
P/E
29.39
52W Low
$82.67
Fwd P/E
13.08
DailyIQ Est.
$130.42
Technical Score (1D)
59
BUY
News Sentiment
69
BULLISH
KKR has announced that its second‑quarter 2026 earnings will be released on August 6, ahead of the NYSE opening, with a live webcast scheduled for 9:00 a.m. ET. The early disclosure gives the market a window to assess the company’s performance before trading begins, potentially influencing intraday pricing momentum in the next few days. Investors should keep an eye on the Q2 results for any guidance on revenue growth, margin trends, and capital allocation plans, as these factors will shape KKR’s valuation outlook over the coming week. In parallel, KKR has emerged as an early bidder for Qiagen, joining EQT and Advent in the takeover chatter, though no formal bid has yet been filed. This interest signals that KKR may be positioning itself for a strategic acquisition that could generate a premium for Qiagen shareholders, thereby affecting the stock’s volatility and valuation expectations in the near term. Traders should monitor for a formal offer from KKR or a counter‑offer from Qiagen, as well as any shifts in Qiagen’s guidance that could alter the takeover narrative. Earlier this week, KKR launched Allyntra, a precision‑engineered solutions platform focused on medical technology and related precision markets, backed by additional capital to acquire complementary businesses. The platform launch expands KKR’s footprint in high‑growth precision industries, potentially diversifying its portfolio and creating new revenue streams that could support long‑term growth. Watch for subsequent announcements on Allyntra’s acquisition pipeline and operational milestones, which will indicate how quickly the platform can generate synergies and impact KKR’s earnings trajectory.
Earnings Summary
KKR & Co. Inc. is a global investment firm that specializes in private equity, real‑estate, and credit strategies across technology, healthcare, and energy sectors, targeting companies with enterprise values between $500 million and $5 billion and typically holding investments for five to seven years. In the financial services sector, KKR’s value proposition centers on identifying and capitalizing on opportunities in both developed and emerging markets, with a focus on North America, Europe, and Asia. In the most recent quarters, KKR’s earnings per share rose from 1.41 in Q3 2025 to 1.12 in Q4 2025, a decline relative to the prior Q2 2025 EPS of 1.18, while revenue fell from $2.40 billion to $1.43 billion, reflecting a slowdown after a strong Q3. In contrast, the preceding two quarters (Q1 2025 and Q2 2025) showed modest EPS growth from 1.15 to 1.18 and revenue increases from $1.77 billion to $1.86 billion, indicating a more consistent upward trend. Across the five quarters with complete data, KKR beat analyst estimates in three quarters (Q4 2024, Q3 2025, Q1 2026) and missed in one (Q4 2025), underscoring a mixed earnings trajectory. Historically, revenue has fluctuated, with a sharp decline in Q4 2024 followed by a rebound in Q3 2025, while EPS has generally trended upward except for the Q4 2025 dip, suggesting that operational performance remains volatile but improving. Recent news highlights KKR’s launch of the Allyntra precision‑engineered solutions platform and a $1.3 billion partnership with SK Inc. to build Korea’s largest renewable‑energy platform, both of which could diversify revenue streams and create new long‑term cash flows; the company also announced an early release of its Q2 2026 earnings, offering investors a window into future guidance. Investors should watch for the Q2 2026 earnings release for guidance on revenue growth, margin trends, and capital allocation plans, monitor the progress of Allyntra’s acquisition pipeline and the regulatory status of the Korean renewable platform, and keep an eye on any formal bid for Qiagen that could signal a strategic acquisition strategy.

EPS

EstBeatMiss
$1.07$1.17$1.27$1.38$1.48Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.43 - -
Q1'26$1.26$1.39+10.3%
Q4'25$1.17$1.12-4.6%
Q3'25$1.30$1.41+8.6%
Q2'25$1.14$1.18+3.6%
Q1'25$1.13$1.15+1.7%

Revenue

EstBeatMiss
$1.3B$1.6B$1.9B$2.3B$2.6BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.5B - -
Q1'26$2.1B$1.5B-30.4%
Q4'25$2.1B$1.4B-30.7%
Q3'25 - $2.4B -
Q2'25 - $1.9B -
Q1'25 - $1.8B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

KKR Stock Snapshot

KKR is currently trading at $96.68, giving KKR & Co. Inc. a market cap of 87.04B and a P/E ratio of 29.4. Today's range spans $95.25–$99.22, with shares opening at $98.00 and moving down $0.26 (0.3%) from the prior close. DailyIQ's technical score sits at 59/100 (HOLD) with a news sentiment reading of 69/100.

Over the past year KKR has traded between $82.67 and $153.87 - the current price is +16.9% off the 52-week low and -37.2% from the high. 28 analysts cover the stock with a Buy consensus and a mean 12-month target of $125.08 (range $105.00–$153.00), implying upside of +29.4%.

The setup for KKR & Co. Inc. (KKR) is neither bullish nor bearish - it's patient. Score: 59/100 (HOLD). Sentiment: bullish (69/100). Price: $96.68 (in the lower half of its 52-week range in $82.67–$153.87). The current P/E ratio stands at 29.4. A large-cap with 87.04B in Financial Services market cap in a neutral technical phase is exactly where position-sizing decisions get made before the next trend emerges.

Portfolio construction in Financial Services often uses large-cap names like KKR as tactical swing positions during neutral phases: cheap enough to overweight, liquid enough to exit quickly, and large enough to provide meaningful sector beta. The current 59/100 (HOLD) at $96.68 (in the lower half of its 52-week range) and bullish sentiment (69/100) frame the position as a catalyst play within the $82.67–$153.87 annual range rather than a directional bet.